SCHEMBL21089631

SCHEMBL21089631

CC(C)C(C)(C)NCCOCCOCC(=O)C(C)(C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PIK3CD O00329 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24211117 0.89 KDM4E (0.39) MEN1KMT2AKDM4EALDH1A1
SCHEMBL24401387 0.86 MEN1 (0.37) MEN1KMT2AKDM4EALDH1A1
SCHEMBL24894989 0.85 MEN1 (0.36) MEN1KMT2AKDM4E
SCHEMBL21089699 0.84
SCHEMBL21090352 0.84 MEN1 (0.35) MEN1KMT2AKDM4E
SCHEMBL21089634 0.82 MEN1 (0.34) MEN1KMT2A
SCHEMBL21937551 0.82 MEN1 (0.34) MEN1KMT2A
SCHEMBL21089825 0.81 MEN1 (0.33) MEN1KMT2A
SCHEMBL24401255 0.77 CES2 (0.33) MEN1KMT2A
SCHEMBL21089618 0.73 MEN1 (0.33) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023284822-A1 FUSION POLYPEPTIDES FOR METABOLIC DISORDERS BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) 2023-01-19 WO disclosed
EP-3226906-B1 GLP-1 DERIVATIVES AND USES THEREOF NOVO NORDISK AS (DK) 2019-06-12 EP disclosed